Autopsy report · NCT04854044

ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“The P.I. is not prepared to move forward at this thime”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: Jonsson Comprehensive Cancer Center
Sponsor type: University, hospital or other
Conditions: Recurrent Glioblastoma; Recurrent Gliosarcoma; Recurrent Supratentorial Glioblastoma; Supratentorial Gliosarcoma
Interventions: Akt/ERK Inhibitor ONC201; Radiation Therapy; Resection
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.